Day 1 - Tuesday, 16 October 2018
Meeting category
Date(s)
16 Oct 2018 - 17 Oct 2018
Location
Rockville,
United States
Organizer
Platinum Level Support
Sponsor logos
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2018
Related Enduring Materials
Enduring Materials
Session 1: Pathogenesis -
Chairs
Cara Wilson, MD
University of Colorado, United States
Sandra Pinto Cardoso, PhD
National Institute of Respiratory Diseases (INER), Mexico
Chemistry from the Microbiome and its role in health and disease
Heathy guts exclude oxygen
Rapid gut epithelial repair at the enteroendocrine-immune intersection through microbiota-mediated rescue of tryptophan metabolism during chronic HIV/SIV infection
HIV-associated gut microbiome differences and concurrent immune activation are dependent on host context (Not yet available)
David Gootenberg
#02
Session 2: Transmission & Prevention -
Chairs
Roger Paredes, MD, PhD
IrsiCaixa AIDS Research Institute, Spain
Laurel Lagenaur PhD
NIH, United States
The role of the intestinal microbiome in modulating HIV transmission risk
Monitoring and modifying the microbiome in the immunocompromised host
DAY 2 - Wednesday, 17 October 2018
Session 3: Comorbidities (Metabolic) -
Chairs
Satya Dandekar, PhD
University of California, Davis, United States
Ronald Collman, MD
University of Pennsylvania's Perelman School of Medicine, United States
Gut microbiota, chronic inflammation and metabolic syndrome
Analysis of gut microbiota composition in ART-treated perinatally HIV-infected patients reveal a distinct profile associated with inflammatory and cardiac biomarkers (Not yet available)
Libera Sessa
#04
HIV COPD: Could differential host recognition of the lung microbiome be contributing to pulmonary disease?
Session 4: Vaccines -
Chairs
Que Dang, PhD
NIH, United States
Angela Malaspina, PhD
NIH, United States
Mucosal microbiomes with HIV infection and protection
Effect of probiotic treatment on SIV/HIV vaccination
A compositional transform reveals HIV exposure induced shifts in the fecal microbiota and vaccine responsiveness of Nigerian infants
Session 5: Therapeutics -
Chairs
Stacy Carrington-Lawrence, PhD
NIH, United States
Frederic Bushman, PhD
University of Pennsylvania, United States
Fecal transplantation from HIV-negative and HIV-positive men to gnotobiotic mice reveals immunological effects of gut microbiota associated with sexual behavior
Overview
Welcome
We are pleased to look back on a very successful 4th International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment, held on the 16th and 17th October 2018 in Rockville, Maryland, USA.
The Organizing Committee and organizers would like to thank the speakers, chairs and all participants for their contribution to this meeting! Special thanks to the workshop support: National Institutes of Health, and sponsors: ViiV Healthcare, Gilead Sciences, Merck, and Seres Therapeutics. Without their contribution this workshop would not have been made possible.
We look forward to seeing you again next year at the 5th International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment, tentatively scheduled in October 2019, in Rockville, Maryland, USA.
The Organizing Committee
General Information
Unique Features
The meeting features for the workshop are to its multidisciplinary nature and significance in enabling to learn how the host microbiome can influence responses to our current HIV therapies, and to further our ability to develop novel prevention and therapeutic strategies for HIV that will lead to the reduction of new HIV infections and the burden of non-communicable diseases in HIV infected subjects.
Meeting Objectives
This meeting aims to:
- To gather cross-disciplinary professionals in the field of microbiome research to provide a better understanding of the impact of microbiome changes on HIV outcomes
- To develop a better understanding of how the microbiome effects the pathogenesis of HIV across mucosal sites
- To enhance our knowledge of how the microbiome can impact vaccine responses
- To better understand how the microbiome can contribute to the development of non-communicable diseases
- To use our knowledge of the microbiome field in developing novel strategies for developing microbicides for HIV prevention
- To bring together scientists from across the globe to enhance our understanding of how we can use approaches to modulate the microbiome to reduce levels of inflammation
- To bring together bioinformatics experts in enhancing our ability to analyze complex data generated by sequencing the host microbiome
- To gather cross-disciplinary professionals in the field of microbiome research to provide a better understanding of the impact of microbiome changes on HIV outcomes
- To develop a better understanding of how the microbiome effects the pathogenesis of HIV across mucosal sites
- To enhance our knowledge of how the microbiome can impact vaccine responses
- To better understand how the microbiome can contribute to the development of non-communicable diseases
- To use our knowledge of the microbiome field in developing novel strategies for developing microbicides for HIV prevention
- To bring together scientists from across the globe to enhance our understanding of how we can use approaches to modulate the microbiome to reduce levels of inflammation
- To bring together bioinformatics experts in enhancing our ability to analyze complex data generated by sequencing the host microbiome
Learning Objectives
After participating in this activity, participants will be able to:
- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium
- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium
- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium
- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium
- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium
- Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium
Practical Information
Language
The official language of the workshop was English.
No simultaneous translation was provided.
No simultaneous translation was provided.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Video recording
All presentations that we were granted permission for will be posted on the workshop website as soon as possible after the meeting is finished, provided the speaker has given permission to do so.
Support
Language
Related Programs
